Literature DB >> 6092465

B cell lines as models for inherited phagocytic diseases: abnormal superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syndrome.

D J Volkman, E S Buescher, J I Gallin, A S Fauci.   

Abstract

Epstein Barr virus (EBV)-transformed B cell lines (BCL) were developed from peripheral blood lymphocytes of individuals with Chediak-Higashi syndrome (CHS) and chronic granulomatous disease (CGD), and were compared to EBV BCL from normals. The cells that were studied expressed both B cell surface antigens and EBV nuclear antigens. BCL from normals contained small cytoplasmic granules. When stimulated with phorbol myristate acetate (PMA), these B cells reduced nitroblue tetrazolium (NBT) and generated significant amounts of superoxide. However, two other phagocytic stimuli, A23187 and f-methionine-leucine-phenylalanine, failed to stimulate BCL oxygen metabolism. BCL from seven individuals with CGD failed to either reduce NBT or generate superoxide on PMA stimulation, although the lines were morphologically similar to BCL from normals. In contrast, CHS-BCL generated superoxide more rapidly than did normals, and contained the characteristic giant granules of CHS. Thus, continuous BCL evidencing the phenotypic abnormalities of inherited human phagocytic diseases can provide large numbers of cells for biochemical and genetic study.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092465

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Voltage-activated proton currents in human lymphocytes.

Authors:  Tom Schilling; Alexander Gratopp; Thomas E DeCoursey; Claudia Eder
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

2.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b.

Authors:  C A Parkos; M C Dinauer; L E Walker; R A Allen; A J Jesaitis; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 3.  Regulation of immune responses by proton channels.

Authors:  Melania Capasso
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

4.  Properties of the superoxide-generating oxidase of B-lymphocyte cell lines. Determination of Michaelis parameters.

Authors:  J T Hancock; F E Maly; O T Jones
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

5.  Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.

Authors:  C Barbey; J M Tiercy; N Fairweather; H Niemann; R Seger; G Corradin
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

6.  Proton channels in non-phagocytic cells of the immune system.

Authors:  Melania Capasso
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2013-03

7.  O2- production by B lymphocytes lacking the respiratory burst oxidase subunit p47phox after transfection with an expression vector containing a p47phox cDNA.

Authors:  S J Chanock; L R Faust; D Barrett; C Bizal; F E Maly; P E Newburger; J M Ruedi; R M Smith; B M Babior
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox.

Authors:  L Zhen; A A King; Y Xiao; S J Chanock; S H Orkin; M C Dinauer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558.

Authors:  P E Newburger; D G Skalnik; P J Hopkins; E A Eklund; J T Curnutte
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease.

Authors:  S Sekhsaria; J I Gallin; G F Linton; R M Mallory; R C Mulligan; H L Malech
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.